Cardlytics

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cardlytics reports robust Q4 performance and eyes positive cash flow

Cardlytics delivered a strong performance in Q4 2022, marked by robust financial results and operational improvements.
The company's strategic focus on cost management, product enhancements, and consumer engagement bodes well for future growth.
While facing challenges in a competitive landscape, Cardlytics is poised to capitalize on opportunities through innovation and strategic initiatives.
Guidance for Q1 2023 and the target for positive free cash flow in Q3 2023 reflect a positive outlook for the company's financial health.

Cardlytics (CDLX) surpasses Q1 expectations amidst cautious advertiser sentiment

Cardlytics (CDLX) reported strong Q1 2023 earnings, exceeding expectations with growth in unique consumers activating offers and improved cost discipline.
The company faces challenges from cautious advertisers and client concentration risks, requiring strategic management and diversification efforts.
Opportunities for growth include expanding the partner network, driving user engagement, and innovating in product offerings to maintain competitiveness.

Cardlytics reports mixed Q2 results, eyes partnerships for growth

Cardlytics navigated mixed financial results in Q2 2023, focusing on cost optimizations and strategic initiatives. The company aims for positive annual adjusted EBITDA and operating cash flow in 2024 amidst market variability and economic uncertainty.

Cardlytics reports positive Q3 results, eyes global expansion and new products

Cardlytics delivered positive Q3 results, showcasing growth in revenue, partnerships, and strategic initiatives. Challenges include revenue factors and product adoption, while opportunities exist in new product offerings and global expansion. The company remains optimistic about future prospects and business success.

Cardlytics reports record Q4 earnings, eyes growth through redemptions

Cardlytics achieved a milestone with its first positive annual adjusted EBITDA since 2019 and recorded its largest adjusted EBITDA in Q4. The company is strategically positioned for growth with new partnerships, product launches, and a focus on driving redemptions. Challenges lie in maintaining financial performance and capital structure.

Cardlytics (CDLX) posts robust Q1 results, eyes growth opportunities

Cardlytics (CDLX) reported strong Q1 2024 results with notable billings and revenue growth, positive adjusted EBITDA, and progress in strategic initiatives. While facing challenges in Q2 projections and analyst inquiries, the company remains focused on capitalizing on growth opportunities and market trends.

Cardlytics reports mixed Q2 results, focuses on growth opportunities

Cardlytics shows resilience with positive adjusted EBITDA in 2023 and improved financial stability
Despite missing Q2 guidance, the company is addressing delivery issues and focusing on growth areas
Strong relationships with financial institutions and plans for business evolution under new leadership
Q3 outlook includes challenges but also opportunities for expansion and performance acceleration

Cardlytics faces Q3 revenue decline, eyes growth through strategic investments

Cardlytics navigated Q3 challenges with a focus on enhancing key aspects of its business. The company's strategic priorities include supply, demand, network performance, and investments in growth initiatives like Bridg and Rippl.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

CDLX Investors Have Capability To Join Cardlytics, Inc. Securities Fraud Investigation With The Schall Law Firm

NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.

CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Investors to Contact the Firm!

NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.

CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Investors to Contact the Firm!

NEW YORK--(BUSINESS WIRE)---- $CDLX #Investigation--The law firm of Kirby McInerney LLP is investigating potential claims against Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX). The investigation concerns whether Cardlytics and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [Click here to learn more about the investigation] On August 7, 2024, Cardlytics reported its financial results for the second quarter ended June 30, 2024, i.

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Cardlytics, Inc. (CDLX)

NEW YORK, NY / ACCESSWIRE / August 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.

Cardlytics Being Investigated on Behalf of Cardlytics, Inc. Investors. Contact Levi & Korsinsky For Details

ATLANTA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) complied with federal securities laws. On August 7, 2024, Cardlytics reported financial results for its second quarter ended June 30, 2024, including a decrease of 9% year-over-year in revenue, stating “our results were challenged by slower-than-anticipated billings growth coupled with higher consumer incentives.” Following this news, the price of the Company's stock dropped.

SHAREHOLDER ALERT: Investigation Into Cardlytics, Inc. (CDLX) Announced byHolzer & Holzer, LLC

NEW YORK, Aug. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ:CDLX) on behalf of Cardlytics stockholders. Our investigation concerns whether Cardlytics has violated the federal securities laws and/or engaged in other unlawful business practices.

CARDLYTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cardlytics, Inc. on Behalf of Cardlytics Stockholders and Encourages Investors to Contact the Firm

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) investors concerning the Company's possible violations of federal securities laws. On August 7, 2024, Cardlytics released its second quarter 2024 financial results, missing consensus estimates due to “slower-than-anticipated billings growth coupled with higher consumer incentives.” Specifically, the Company stated that it had enco.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cardlytics, Inc. (CDLX) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Cardlytics investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securitie.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cardlytics, Inc. (CDLX) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On August 7, 2024, Cardlytics released its second quarter 2024 financial results, missing consensus estimates due to “slower-than-anticipated billings growth coupled with hi.

The Law Offices of Frank R. Cruz Announces Investigation of Cardlytics, Inc. (CDLX) on Behalf of Investors

NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.

Cardlytics, Inc. (CDLX) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates

SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Cardlytics, Inc. (NASDAQ: CDLX) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.

Johnson Fistel Begins Investigation into Cardlytics Following a Significant Drop in the Company's Stock

Cardlytics (NASDAQ: CDLX ) stock is falling hard on Thursday after the advertising platform operator released its latest earnings and announced a leadership change. The bad news in the earnings report starts with its revenue of $69.64 million.

Why Is Cardlytics (CDLX) Stock Down 57% Today?

ATLANTA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the second quarter ended June 30, 2024.

Cardlytics Announces Second Quarter 2024 Financial Results

ATLANTA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced that the Board of Directors has appointed Amit Gupta, Chief Operating Officer and General Manager of Bridg, as its next Chief Executive Officer of Cardlytics, effective August 16, 2024. He will also join the Cardlytics Board of Directors on that date. Mr. Gupta will succeed Karim Temsamani, who is stepping down as Chief Executive Officer and from the Board of Directors to pursue another professional opportunity.

Cardlytics Appoints Amit Gupta as CEO

ATLANTA, July 24, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its second quarter ended June 30, 2024 financial results will be released on August 7, 2024, after market close. The results will be discussed via conference call at 5:00 PM (ET) / 2:00 PM (PT).

Cardlytics Announces Timing of Its Second Quarter 2024 Earnings Release

Cardlytics beat on earnings but missed on sales last night. Investors appear to be overreacting -- but actually, they're justified considering the size of Cardlytics' Q1 loss.

Why Cardlytics Stock Collapsed on Thursday

Cardlytics (NASDAQ: CDLX ) stock is falling on Thursday after the advertising platform operator released its earnings report for the first quarter of 2024. That earnings report starts with revenue of $67.61 million for the quarter.

Why Is Cardlytics (CDLX) Stock Down 29% Today?

Cardlytics, Inc. (NASDAQ:CDLX ) Q1 2024 Earnings Conference Call May 8, 2024 5:00 PM ET Company Participants Nick Lynton - Chief, Legal and Privacy Officer Karim Temsamani - CEO Alexis DeSieno - CFO Conference Call Participants Kyle Peterson - Needham Jason Kreyer - Craig Hallum Jacob Stephan - Lake Street Capital Markets Operator Good day and thank you for standing by. Welcome to the Cardlytics Earnings Conference Call.

Cardlytics, Inc. (CDLX) Q1 2024 Earnings Call Transcript

ATLANTA, May 08, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the first quarter ended March 31, 2024.

Cardlytics Announces First Quarter 2024 Financial Results

ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that, on May 1, 2024, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 38,500 restricted stock units of Cardlytics to five newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”).

Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bank of America

Cardlytics recently appointed Liane Hornsey to its Board of Directors, which could attract new investors and accelerate hiring and productivity.

The Power Of Cardlytics' Data Partnerships Including Bank of America

ATLANTA, April 09, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, is excited to announce the appointment of Liane Hornsey to its Board of Directors. In connection with her appointment to the Board of Directors, Hornsey was also appointed to the Board's Compensation Committee, and she will assume the role of Compensation Committee Chairperson upon Cardlytics' upcoming Annual Meeting of Stockholders in May 2024.

Liane Hornsey Appointed to Cardlytics Board of Directors

Cardlytics stock skyrocketed because its business showed improved trends. The company then refinanced some of its debt at a higher rate, which troubled investors.

Why Cardlytics Stock Skyrocketed 75% Last Month

ATLANTA, March 26, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX) (“Cardlytics”), an advertising platform in banks' digital channels, today announced the pricing of its offering of $150.0 million aggregate principal amount of 4.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes are scheduled to settle on April 1, 2024, subject to customary closing conditions. Cardlytics also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $22.5 million aggregate principal amount of notes.

News for Cardlytics Stock (CDLX)